Autism Spectrum Disorders (ASD) Characterization Study
A Characterization Study of Individuals With Autism Spectrum Disorders
1 other identifier
observational
26
1 country
1
Brief Summary
The overarching aim of the study is to characterize children and adults with ASDs, and compare them with age-matched controls in relation to their functioning in family, academic, employment, and social spheres. Subjects will be comprehensively assessed in multiple non-overlapping domains of functioning, using psychiatric, cognitive, and psychosocial instruments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 2, 2008
CompletedFirst Posted
Study publicly available on registry
December 3, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2010
CompletedOctober 22, 2013
October 1, 2013
1.5 years
December 2, 2008
October 21, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall level of functioning of children and adults with autism spectrum disorders (ASD) compared to individuals without ASD.
single time point
Study Arms (2)
ASD
Children and adults with Autism Spectrum Disorders.
Non-ASD
Healthy volunteers who have never been diagnosed with an Autism Spectrum Disorder in their lifetime.
Eligibility Criteria
Children and adults with ASDs. Controls: healthy volunteers who have never been diagnosed with an Autism Spectrum Disorder.
You may qualify if:
- Age: 6-60 years old
- For subjects who have ASD: Meet DSM-IV PDD criteria based on clinical assessment including PDD module of structured interview
- For subjects who have ASD: One parent/guardian available for interviews about each subject. If a parent or guardian is not available, a reliable adult reporter identified by the subject available for an interview
- Full-scale IQ of above 80
You may not qualify if:
- Major sensorimotor handicaps (e.g. deafness, blindness)
- Any severely unstable psychiatric conditions including the following: psychosis, suicidality, bipolar disorder, substance use disorders (alcohol or drugs) that would require in-patient hospitalization.
- Inadequate command of the English language.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Cambridge, Massachusetts, 02138, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph Biederman, MD
Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief, Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD; Professor of Psychiatry, Harvard Medical School
Study Record Dates
First Submitted
December 2, 2008
First Posted
December 3, 2008
Study Start
October 1, 2008
Primary Completion
April 1, 2010
Study Completion
April 1, 2010
Last Updated
October 22, 2013
Record last verified: 2013-10